Anaesthesiology and Intensive Care Department, European Hospital Georges-Pompidou, Paris, 75015 France; INRIA Paris-Saclay University, 91120 Palaiseau, France; LMS, Paris-Saclay University, 91120 Palaiseau, France.
Anaesthesiology and Intensive Care Department, European Hospital Georges-Pompidou, Paris, 75015 France; Paris Descartes University, Sorbonne Paris Cité, Paris, France.
Anaesth Crit Care Pain Med. 2018 Jun;37(3):259-268. doi: 10.1016/j.accpm.2017.08.007. Epub 2017 Oct 13.
The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a salvage therapy in cardiogenic shock is becoming of current practice. While VA-ECMO is potentially a life-saving technique, results are sometimes mitigated, emphasising the need for selecting the right indication in the right patient. This relies upon a clear definition of the individual therapeutic project, including the potential for recovery as well as the possible complications associated with VA-ECMO. To maximise the benefits of VA-ECMO, the basics of extracorporeal circulation should be perfectly understood since VA-ECMO can sometimes be detrimental. Hence, to be successful, VA-ECMO should be used by teams with sufficient experience and initiated after a thorough multidisciplinary discussion considering patient's medical history, pathology as well the anticipated evolution of the disease.
将静脉-动脉体外膜肺氧合（VA-ECMO）用作心源性休克的抢救治疗方法目前已较为常见。虽然 VA-ECMO 是一种有潜在救生能力的技术，但有时其结果会受到影响，这强调了在合适的患者中选择合适适应证的必要性。这依赖于明确定义个体化治疗方案，包括恢复的可能性以及与 VA-ECMO 相关的可能并发症。为了最大限度地提高 VA-ECMO 的益处，应完全理解体外循环的基本知识，因为 VA-ECMO 有时可能会带来危害。因此，VA-ECMO 应由具有足够经验的团队使用，并在进行彻底的多学科讨论后，根据患者的病史、病理学以及疾病的预期进展来启动。
